The viability of mesoporous silica nanoparticles for drug delivery

Research output: Contribution to journalReview Article or Literature ReviewScientificpeer-review

9 Citations (Scopus)

Abstract

Encapsulation of potent drugs within nanocarriers that selectively target diseased cells raises high hopes to increase the efficacy of conventional drug delivery and decrease side effects. Mesoporous silica nanoparticles (MSNs), whose characteristic properties include uniform mesopores, facile and flexible surface functionalization and appreciable biocompatibility have gained much recent attention for facilitating biomedical applications.
Original languageUndefined/Unknown
Pages (from-to)891–893
JournalTherapeutic Delivery
Volume6
Issue number8
DOIs
Publication statusPublished - 2015
MoE publication typeA2 Review article in a scientific journal

Cite this